Compare PLUR & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLUR | ATCH |
|---|---|---|
| Founded | 2001 | 2022 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 29.6M |
| IPO Year | 2001 | 2024 |
| Metric | PLUR | ATCH |
|---|---|---|
| Price | $2.09 | $0.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $1.00 |
| AVG Volume (30 Days) | 10.1K | ★ 1.5M |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $1,336,000.00 | N/A |
| Revenue This Year | $97.38 | $84.47 |
| Revenue Next Year | $293.97 | $39.32 |
| P/E Ratio | ★ N/A | $4.10 |
| Revenue Growth | ★ 309.82 | N/A |
| 52 Week Low | $1.99 | $0.14 |
| 52 Week High | $5.96 | $1.92 |
| Indicator | PLUR | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | 44.42 |
| Support Level | N/A | $0.19 |
| Resistance Level | $2.58 | $0.22 |
| Average True Range (ATR) | 0.12 | 0.01 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 22.73 | 45.53 |
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.